Source: Frontiers in Endocrinology. Unidades: FMRP, ICB
Subjects: CÓRTEX ADRENAL, FATOR DE TRANSCRIÇÃO AP-1, CÉLULAS CULTIVADAS DE TUMOR, MARCADOR MOLECULAR, ADENOMA, CARCINOMA, EXPRESSÃO GÊNICA
ABNT
PASSAIA, Bárbara dos Santos et al. TCF21/POD-1, a transcritional regulator of SF-1/NR5A1, as a potential prognosis marker in adult and pediatric adrenocortical tumors. Frontiers in Endocrinology, v. 9, p. 14 , 2018Tradução . . Disponível em: https://doi.org/10.3389/fendo.2018.00038. Acesso em: 31 ago. 2024.APA
Passaia, B. dos S., Dias, M. H. dos S., Kremer, J. L., Antonini, S. R. R., Almeida, M. Q. de, Fragoso, M. C. B. V., & Lotfi, C. F. P. (2018). TCF21/POD-1, a transcritional regulator of SF-1/NR5A1, as a potential prognosis marker in adult and pediatric adrenocortical tumors. Frontiers in Endocrinology, 9, 14 . doi:10.3389/fendo.2018.00038NLM
Passaia B dos S, Dias MH dos S, Kremer JL, Antonini SRR, Almeida MQ de, Fragoso MCBV, Lotfi CFP. TCF21/POD-1, a transcritional regulator of SF-1/NR5A1, as a potential prognosis marker in adult and pediatric adrenocortical tumors [Internet]. Frontiers in Endocrinology. 2018 ; 9 14 .[citado 2024 ago. 31 ] Available from: https://doi.org/10.3389/fendo.2018.00038Vancouver
Passaia B dos S, Dias MH dos S, Kremer JL, Antonini SRR, Almeida MQ de, Fragoso MCBV, Lotfi CFP. TCF21/POD-1, a transcritional regulator of SF-1/NR5A1, as a potential prognosis marker in adult and pediatric adrenocortical tumors [Internet]. Frontiers in Endocrinology. 2018 ; 9 14 .[citado 2024 ago. 31 ] Available from: https://doi.org/10.3389/fendo.2018.00038